Ablynx NV has hired Robert Zeldin as chief medical officer to lead global clinical development of the company’s portfolio of therapeutic proteins. Dr Zeldin, who is a medical doctor and a former assessor at the US Food and Drug Administration, also has significant pharmaceutical industry experience. This includes senior positions at both Merck & Co Inc and Novartis Pharmaceuticals Corp where he headed drug development teams in immunology, respiratory, dermatology and cardiovascular medicine.
The appointment took effect on 1 December 2015.
Copyright 2015 Evernow Publishing Ltd